Sight Sciences Announces First Patient Treated in TRIDENT European Trial to Evaluate the OMNI® Surgical System in Pseudophakic Eyes with Open-Angle Glaucoma
Sight Sciences, Inc. (Nasdaq: SGHT), an eyecare technology company focused on creating innovative solutions intended to transform care and improve patients’ lives, today announced that the first patient has been treated in the novel TRIDENT ...
Equipment & Solutions
Vest for the postoperative period following arm and back liposuction. Opens at the front with three rows of hook-and-eye closures. The garment has a discreet low cut neckline.